Skip to main content
PCL. Inc logo

PCL. Inc — Investor Relations & Filings

Ticker · 241820 ISIN · KR7241820000 KO Manufacturing
Open in API
Filings indexed 684 across all filing types
Latest filing 2022-03-14 Regulatory Filings
Country KR South Korea
Listing KO 241820

About PCL. Inc

http://www.pclchip.com/

PCL, Inc. is a company that develops and manufactures in-vitro diagnostic (IVD) medical devices, specializing in multiplex immunodiagnosis. The company's core offering is based on its proprietary SG Cap™ Technology, a platform for creating advanced diagnostic solutions. Its product portfolio includes automated multi-immune diagnostic systems, blood testing kits, cancer screening tests, and rapid antigen kits. PCL also provides platform services, reagents, and related equipment such as desktop arrayers to the medical and diagnostic fields.

Recent filings

Filing Released Lang Actions
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from the Korean DART system regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details a contract amendment (correction report) for a supply agreement with Haemo Pharma GmbH. Since this is a specific regulatory announcement regarding a commercial contract and does not fit into the other specialized categories like M&A or financial reports, it is classified as a general regulatory filing.
2022-03-14 Korean
[기재정정]주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice regarding the convocation of a General Meeting of Shareholders (주주총회소집결의) for the company PCL. It details the date, location, and agenda items (such as financial statement approval, director appointments, and articles of incorporation changes). This type of document is a standard proxy solicitation or notice of meeting material provided to shareholders to inform them of upcoming voting matters.
2022-03-14 Korean
주주총회집중일개최사유신고
AGM Information Classification · 98% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company, PCL, is holding its AGM on a date that coincides with other companies' meetings, citing operational constraints. Since this is a specific regulatory disclosure regarding meeting logistics rather than the meeting materials themselves, the AGM results, or a proxy statement, it falls under the general regulatory filing category.
2022-03-14 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sale/Supply Contract' (단일판매ㆍ공급계약체결). It details a contract amendment and disclosure of previously withheld information regarding a supply agreement with 'Bakter Medical'. Since this is a specific regulatory disclosure of a material contract event filed with the financial authorities, it falls under the 'Regulatory Filings' category as it does not fit into the specific categories like M&A or Share Issues.
2022-03-11 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sales/Supply Contract' amendment. It details the correction of a previous disclosure (dated 2021.03.10) due to the expiration of a confidentiality period regarding the counterparty (GFE Blut). Since this is a specific regulatory disclosure regarding a contract amendment and does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2022-03-08 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from a Korean company (PCL) regarding a 'Single Sales/Supply Contract' amendment. It details the correction of a previous disclosure (dated 2021-03-10) to reveal the counterparty name (Bakter Medical) after a confidentiality period expired. Since this is a specific regulatory disclosure regarding a contract update and does not fit into categories like M&A, dividends, or financial reports, it falls under the general regulatory filing category.
2022-03-08 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.